Low Bone Mineral Density in Chinese Adults with Nonalcoholic Fatty Liver Disease

Table 3

Influence of variables on BMD in different groups.

	Males			Females
	Control	NAFLD	𝑃	Control	NAFLD	𝑃
CTX (ng/mL)	0.40±0.24	0.34±0.23	0.158	0.44±0.31	0.40±0.21	0.440
PTH (pg/mL)	14.66±23.45	14.17±17.40	0.908	17.38±23.24	16.25±22.84	0.786
OC (IU/L)	12.95±10.68	10.84±4.53	0.568	14.61±8.79	14.30±5.80	0.814
CT (IU/L)	74.68±51.07	87.87±56.12	0.224	83.92±52.69	71.47±59.07	0.227
BAP (IU/L)	170.57±25.45	174.89±32.41	0.459	169.13±23.80	170.89±25.81	0.899
25(OH)D (IU/L)	47.55±15.16	44.07±14.45	0.248	48.52±16.43	46.74±24.18	0.646
Calcium (mmol/L)	2.21±0.14	2.28±0.12	0.017*	2.25±0.13	2.30±0.11	0.015*
HOMA2%B	133.96±97.03	137.67±82.60	0.839	115.29±76.54	140.95±80.59	0.076
HOMA2%S	52.50±135.48	23.14±13.52	0.147	76.65±198.97	21.69±12.49	0.020*
HOMA2IR	4.44±2.41	5.41±2.38	0.047*	3.94±2.68	5.88±2.55	<0.001*

CTX: type I collagen; PTH: parathyroid hormone; OC: osteocalcin; CT: calcitonin; BAP: bone alkaline phosphatase; 25(OH)D: 25-hydroxyl-vitamin D; HOMA2%B: homeostasis model assessment 2 of 𝛽 cell function; HOMA2%S: homeostasis model assessment 2 of insulin sensitivity; HOMA2IR: homeostasis model assessment 2 of insulin resistance. ^∗𝑃<0.05.